Literature DB >> 2221851

Capsaicin for the treatment of pain in Guillain-Barré syndrome.

J C Morgenlander, B J Hurwitz, E W Massey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2221851     DOI： 10.1002/ana.410280222

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  8 in total

1.  Topical diclofenac for the treatment of eyeache in Miller-Fisher syndrome.

Authors:  Ji Soo Kim; Jeong-Min Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

Review 2.  Peppers and pain. The promise of capsaicin.

Authors:  B M Fusco; M Giacovazzo
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 3.  Pharmacological treatment for pain in Guillain-Barré syndrome.

Authors:  Jia Liu; Lu-Ning Wang; Ewan D McNicol
Journal:  Cochrane Database Syst Rev       Date:  2015-04-09

Review 4.  Headache and Pain in Guillain-Barré Syndrome.

Authors:  Constantine Farmakidis; Seniha Inan; Mark Milstein; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2015-08

Review 5.  Vanilloid receptor ligands: hopes and realities for the future.

Authors:  A Szallasi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients.

Authors:  Benigno Casanueva; Baltasar Rodero; Covadonga Quintial; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2012-07-28       Impact factor: 2.631

Review 7.  Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.

Authors:  C Rains; H M Bryson
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

8.  Topical preparations for pain relief: efficacy and patient adherence.

Authors:  Liliana L Jorge; Caroline C Feres; Vitor Ep Teles
Journal:  J Pain Res       Date:  2010-12-20       Impact factor: 3.133
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.